Clostridium botulinum neurotoxin type A, free from complexing proteins

Details

Files

Generic Name:

Project Status:

Complete

Therapeutic Area:

Blepharospasm

Manufacturer:

Merz Pharmaceuticals GmbH

Brand Name:

Xeomin

Project Line:

Reimbursement Review

Project Number:

SR0168-000

Performance Metric:

N/A — Predated performance metrics

Submission Type:

Initial

Indications:

Blepharospasm

Recommendation Type:

List in a similar manner

Final Recommendation:

December 16, 2009

Last Updated : June 12, 2009